Uptake of intermittent preventive treatment with sulphadoxine-pyrimethamine for malaria during pregnancy and pregnancy outcomes: a cross-sectional study in Geita district, North-Western Tanzania

Table 2 Factors associated with uptake of three or more doses of IPTp-SP among delivering women

Variable	IPTp-SP uptake		COR (95% CI)	P-value	AOR (95% CI)	P-value
	N	≥3 doses, n (%)
Maternal age
<20 years	97	3 (3.09)	Reference		Reference
≥20 years	334	23 (6.89)	2.33 (0.68-7.87)	0.179	2.33 (0.63-9.09)	0.203
Marital status
Single	74	7 (9.49)	1.86 (0.75-4.60)	0.180	2.37 (0.84-6.67)	0.103
Married	357	19 (5.32)	Reference		Reference
Health facility
Katoro HC	166	2 (1.20)	Reference		Reference
Geita hospital	265	24 (9.06)	8.20 (1.90-34.48)	0.005	8.33 (1.79-33.33)	0.007
Level of education
None/Primary	360	15 (4.17)	Reference		Reference
Secondary/Higher	71	11 (15.49)	4.22 (1.85-9.62)	0.001	1.69 (0.66-4.35)	0.275
Occupation
Peasants	370	16 (4.32)	Reference		Reference
Employed/business	61	10 (16.39)	4.35 (1.85-10.10)	0.001	1.85 (0.70-5.00)	0.214
ANC visits
<4 visits	276	8 (2.90)	Reference		Reference
≥4 visits	155	18 (11.61)	4.41 (1.87-10.42)	0.001	4.35 (1.79-11.11)	0.001

ANC: antenatal care; AOR: adjusted odds ratio; COR: crude odds ratio; IPTp-SP: intermittent preventive treatment of malaria in pregnancy with sulphadoxine-pyrimethamine; Significant p-values are presented in bold.

ISSN: 1475-2875